Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs

Ann Intern Med. 1985 Apr;102(4):476-9. doi: 10.7326/0003-4819-102-4-476.

Abstract

Immunoglobulin G antibodies to lymphadenopathy-associated virus have been detected in two groups of French hemophiliacs and in one group of Belgian hemophiliacs, whose mode of treatment differed. Seropositivity was more frequent (58.9%) in patients heavily transfused with blood products of French and foreign origin than in less frequently transfused persons (10.3%). The Belgian group, treated only with local products, showed the lowest frequency of seropositivity (3.4%). In healthy French controls, 1 of 330 had antibody to the virus. The results indicate transmission of lymphadenopathy-associated virus via blood-derived products.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral / analysis*
  • Belgium
  • Deltaretrovirus / immunology*
  • Factor IX / therapeutic use
  • Factor VIII / therapeutic use
  • France
  • Hemophilia A / therapy*
  • Hemophilia B / immunology
  • Hemophilia B / therapy
  • Humans
  • Immunoglobulin G / analysis*
  • Male
  • Retroviridae Infections / epidemiology*
  • Serologic Tests

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Factor VIII
  • Factor IX